Keyword: «sanctions»

The article examines the historical aspects of the development of the pharmaceutical indus-try in Russia, the economic features of the development and production of pharmaceutical substances and medicines, as well as the problems faced by the industry with the beginning of sanctions restrictions. The author evaluates the state import substitution programs, the purpose of which is to reduce dependence on the import of medicines and pharmaceutical substances to Russia. The dynamics of the pharmaceutical market growth, as well as the dynamics of the decrease in the import of medicines from foreign countries are analyzed. Based on the analysis, conclusions were drawn about the failure to achieve the targets stated in state programs and the continued dependence on imported medicines. However, we can note a positive trend of increasing funding for research in the pharmaceutical industry, and the creation of own samples of medicines is also proceeding at an accelerated pace.

In connection with the sanctions conditions, Russia is turning to the East, which has a positive effect on Russian-Chinese trade and economic cooperation. Russia's focus on import substitution must be gradually reduced and its industries developed, which is what our country's policy is aimed at. Under the current conditions, it is difficult to immediately solve this problem, which is why Russia is focused on import substitution from China.

Sanctions designed to break Russia’s foreign trade relations and cut off Western financial flows were supposed to cause “financial starvation” of economic entities, but these plans were violated by the actions of our government. However, other objective factors played an important role in this, such as: firstly, the deep integration of the state into the economy, secondly, the high share of the shadow economy, and the third factor – the real sector of the economy in recent years has existed under the conditions of a “financial hunger." These factors contributed to the Russian economy's resistance to adverse impacts, and enabled it to develop in new conditions.

Mergers and acquisitions in the Russian market have recently acquired a new meaning. While earlier deals were made to strengthen market positions in the conditions of global competition and attract investments, now companies seek to merge in order to preserve their position and the stability of industries and market system within the country. In this regard, it is important to study the market of mergers and acquisitions to understand the prospects for further development of business entities, society, especially in the current crisis phenomena. The purpose of the article: to study the impact of the crisis phenomena of recent years – pandemic coronovirus and sanctions against Russia – on M&A transactions, in identifying new trends and features of these transactions in the Russian market in the period from 2019 to 2023. The research reveals new trends that have emerged in the market, including the forced nature of deals and the lack of completeness. It shows the main drivers and features that contributed to the active development of Russian industries and further growth of domestic deals, including loss of access to cheap debt, change of target setting and industry leaders. Methods: the paper uses systematization and generalization of scientific material, statistical data and expert community opinion on the problem under consideration, logical, structural, retrospective analysis and synthesis.